← back to search

Mei Zhang

University of Otago · NZ
🔎 Find collaborators in Molecular Biology · Hematology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Hematology
Research interest
Research focused on Myeloid leukemia and Oxaliplatin, with related work in Cancer research, Thalidomide, Arsenic trioxide. Notable publications include 'Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study', 'Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma', and 'CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma'.
h-index
—
citations
108
works
4
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Near-infrared spatiotemporal color vision in humans enabled by upconversion contact lenses
Cell 2025cited by 35position: middledoi
CACA guidelines for holistic integrative management of adult acute myeloid leukemia
Holistic Integrative Oncology 2024cited by 3position: middledoi
Women and girls with haemophilia: A retrospective cohort study in China
Haemophilia 2023cited by 6position: middledoi
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
Heliyon 2023cited by 5position: middledoi
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study
Clinical Cancer Research 2020cited by 55position: middledoi
Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma
BMC Cancer 2020cited by 46position: middledoi
CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma
Hepatology International 2019cited by 39position: middledoi
MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2019cited by 13position: lastdoi
Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study
Cancer Chemotherapy and Pharmacology 2017cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yang Bu · Fudan University2 papers (2019–2020)Xuelian Xiao · The Ohio State University Wexner Medical Center2 papers (2019–2020)Xia Liao · Southwest University2 papers (2019–2020)Fan Chang · North Sichuan Medical University2 papers (2019–2020)— · 2 papers (2019–2020)Qingan Jia · Fudan University2 papers (2019–2020)Dong Liu · Harbin Medical University1 papers (2019–2019)Xiaomin Wang · Yulin Normal University1 papers (2023–2023)Zhiguo Wang · South China Agricultural University1 papers (2019–2019)Xuefeng Wang · Xuzhou Medical College1 papers (2023–2023)Xuejiao Ren · Changchun University of Science and Technology1 papers (2020–2020)Ge Song · Qingdao University1 papers (2020–2020)Ge Song · Zhejiang University1 papers (2019–2019)Xinsheng Zhang · Jilin University1 papers (2023–2023)Lingling Chen · Guangzhou University of Chinese Medicine1 papers (2023–2023)Hongli Zhao · Harbin Medical University1 papers (2019–2019)Zihan Xu · Jiangnan University1 papers (2020–2020)— · 1 papers (2023–2023)— · 1 papers (2023–2023)— · 1 papers (2023–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Hematology →